Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07825259) titled 'A Study of Itraconazole and Posaconazole for Chronic Pulmonary Aspergillosis' on Sept. 11.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
Condition:
Chronic Pulmonary Aspergillosis
Intervention:
Drug: Posaconazole Delayed Release Oral Tablet
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: November 1, 2026
Target Sample Size: 220
Countries of Recruitment:
India
To kn...